
Ray Therapeutics
Developer of optogenetic gene therapies designed for vision restoration purposes. The company utilizes bioengineered light-sensitive proteins delivered to targeted retinal cells through intravitreal i...
Valuation
$0
Share Price
N/A
Total Raised
$106M
Last Round
N/A